Abstract:Obesity represents an escalating global health burden with profound medical and economic impacts. The conventional perspective on obesity revolves around its classification as a "pure" metabolic disorder, marked by an imbalance between calorie consumption and energy expenditure. Present knowledge, however, recognizes the intricate interaction of rare or frequent genetic factors that favor the development of obesity, together with the emergence of neurodevelopmental and mental abnormalities, phenotypes that are modulated by environmental factors such as lifestyle. Thirty years of human genetic research has unveiled >20 genes, causing severe early-onset monogenic obesity and ~1000 loci associated with common polygenic obesity, most of those expressed in the brain, depicting obesity as a neurological and mental condition. Therefore, obesity's association with brain function should be better recognized. In this context, this review seeks to broaden the current perspective by elucidating the genetic determinants that contribute to both obesity and neurodevelopmental and mental dysfunctions. We conduct a detailed examination of recent genetic findings, correlating them with clinical and behavioral phenotypes associated with obesity. This includes how polygenic obesity, influenced by a myriad of genetic variants, impacts brain regions associated with addiction and reward, differentiating it from monogenic forms. The continuum between non-syndromic and syndromic monogenic obesity, with evidence from neurodevelopmental and cognitive assessments, is also addressed. Current therapeutic approaches that target these genetic mechanisms, yielding improved clinical outcomes and cognitive advantages, are discussed. To sum up, this review corroborates the genetic underpinnings of obesity, affirming its classification as a neurological disorder that may have broader implications for neurodevelopmental and mental conditions. It highlights the promising intersection of genetics, genomics, and neurobiology as a foundation for developing tailored medical approaches to treat obesity and its related neurological aspects.

Syndromic and Monogenic Obesity: New Opportunities Due to Genetic-Based Pharmacological Treatment

Rare genetic forms of obesity in childhood and adolescence: A narrative review of the main treatment options with a focus on innovative pharmacological therapies

[A Clinical Challenge of Evaluation and Management in Children with Genetic Obesity].

Mendelian obesity, molecular pathways and pharmacological therapies: a review

Latest approaches for the treatment of obesity

Rare Genetic Forms of Obesity: Clinical Approach and Current Treatments in 2016

Updates on Monogenic Obesity in a Multifactorial Disease

Obesity: exploring its connection to brain function through genetic and genomic perspectives

Advances in Anti-obesity Pharmacotherapy: Current Treatments, Emerging Therapies, and Challenges

Syndromic obesity with neurodevelopmental delay: Opportunities for targeted interventions

A comprehensive review of genetic causes of obesity

A Review of Genes Associated with Obesity Susceptibility: Findings from Association Studies

The Genetic Basis of Childhood Obesity: A Systematic Review

The expanding landscape of genetic causes of obesity

Rare genetic forms of obesity: From gene to therapy

New Incretin Combination Treatments under Investigation in Obesity and Metabolism: A Systematic Review

A genomics perspective of personalized prevention and management of obesity

Deciphering the genetic landscape of obesity: a data-driven approach to identifying plausible causal genes and therapeutic targets

The genetics of childhood obesity and interaction with dietary macronutrients

New pharmacological approaches for obesity management

New insights into the treatment of obesity.